In mucosal sites, aberrant immune function and cross-reactivity of CD4 TRM in peripheral tissues are being investigated in inflammatory bowel disease (IBD) and asthma as possible causes of chronic or remitting immunopathology. Here, CD4 is linked to inflammatory bowel disease.